iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
- 21 June 2018
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 131 (25), 2745-2760
- https://doi.org/10.1182/blood-2017-09-806398
Abstract
The previous edition of the consensus guidelines of the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), published in 2008, has found broad acceptance by physicians and investigators caring for patients with CLL. Recent advances including the discovery of the genomic landscape of the disease, the development of genetic tests with prognostic relevance, and the detection of minimal residual disease (MRD), coupled with the increased availability of novel targeted agents with impressive efficacy, prompted an international panel to provide updated evidence- and expert opinion–based recommendations. These recommendations include a revised version of the iwCLL response criteria, an update on the use of MRD status for clinical evaluation, and recommendations regarding the assessment and prophylaxis of viral diseases during management of CLL.Keywords
This publication has 126 references indexed in Scilit:
- Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximabLeukemia, 2013
- Screening older cancer patients: first evaluation of the G-8 geriatric screening toolAnnals of Oncology, 2012
- Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemiaLeukemia & Lymphoma, 2011
- The Tumor Lysis SyndromeThe New England Journal of Medicine, 2011
- Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with RituximabCase Reports in Oncology, 2011
- Chronic lymphocytic leukemia and autoimmunity: a systematic reviewHaematologica, 2011
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotypingLeukemia, 2007
- Health-Related Quality of Life in Younger Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine Plus Cyclophosphamide or Fludarabine Alone for First-Line Therapy: A Study by the German CLL Study GroupJournal of Clinical Oncology, 2007
- The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoireImmunology Today, 1994